Form 4: Upstream Bio, Inc. Insider Sells Shares for Tax Withholding

Sentiment:

Statement of Changes in Beneficial Ownership


Upstream Bio, Inc. reports that General Counsel Allison Ambrose sold 477 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Summary

  • Allison Ambrose, General Counsel of Upstream Bio, Inc., reported a transaction on June 16, 2026.
  • The transaction involved the sale of 477 shares of common stock.
  • These shares were sold at a price of $6.10 per share.
  • The sale was conducted under the company's 'sell-to-cover' policy to satisfy tax withholding obligations.
  • This policy automatically sells shares to cover taxes upon the vesting of restricted stock units.
  • The sales were not at the discretion of the reporting person.
  • Following this transaction, Allison Ambrose beneficially owns 16,048 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine transaction for tax compliance rather than a strategic business development or a significant change in insider holdings.

Positives

  • The transaction was executed under a pre-defined company policy ('sell-to-cover') designed to manage tax obligations automatically.
  • The sale was not a discretionary decision by the reporting person, indicating adherence to established procedures.
  • The reporting person continues to hold a significant number of shares (16,048) after the transaction.

Negatives

  • A portion of the reporting person's holdings was sold, reducing their direct ownership.

Risks

  • Potential for future sales under the 'sell-to-cover' policy if more restricted stock units vest and trigger tax obligations.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a past transaction.

Management Comments

  • The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person.
  • The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The 'sell-to-cover' policy is a common mechanism for executives to manage tax liabilities arising from equity compensation without needing to make discretionary sales.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Adoption of PolicyThe Issuer has adopted a 'sell-to-cover' policy to satisfy tax withholding obligations for reporting persons.Not specified, but in effect as of 06/16/2026Facilitates automatic settlement of tax liabilities arising from equity compensation, reducing discretionary risk for management.

Stakeholder Impact

  • Shareholders: The sale of a small number of shares by an insider for tax purposes is unlikely to have a significant impact on the share price or overall company performance. The continued holding of a large number of shares by the insider may be viewed positively.
  • Employees: The 'sell-to-cover' policy is a standard benefit for employees receiving equity compensation, ensuring tax obligations are met without personal financial strain.
  • Management: Provides a clear and automatic mechanism for managing tax liabilities associated with equity awards.

Next Steps

  • Continued adherence to the 'sell-to-cover' policy for future tax withholding obligations related to equity awards.

Key Dates

DateDescription
06/16/2026Earliest transaction date and transaction date for the sale of common stock.
06/17/2026Date of signature for the Form 4 filing.

Keywords

Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Upstream Bio, Inc., General Counsel, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.